Order Article Reprints

Teijeira L, Martínez M, Moreno A, de Elejoste I, Ibáñez-Beroiz B, Arrazubi V, Díaz de Corcuera I, Elejalde I, Campillo-Calatayud A, Les I. Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy: A Multicenter, Prospective, Observational, Pan-Cancer Cohort Study with a Gender Perspective. Cancers. 2024; 16(1):151. https://doi.org/10.3390/cancers16010151

Teijeira, Lucía, Mireia Martínez, Amaia Moreno, Ibone de Elejoste, Berta Ibáñez-Beroiz, Virginia Arrazubi, Isabela Díaz de Corcuera, Iñaki Elejalde, Ana Campillo-Calatayud, and Iñigo Les. 2024. "Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy: A Multicenter, Prospective, Observational, Pan-Cancer Cohort Study with a Gender Perspective" Cancers 16, no. 1: 151. https://doi.org/10.3390/cancers16010151

Teijeira, L., Martínez, M., Moreno, A., de Elejoste, I., Ibáñez-Beroiz, B., Arrazubi, V., Díaz de Corcuera, I., Elejalde, I., Campillo-Calatayud, A., & Les, I. (2024). Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy: A Multicenter, Prospective, Observational, Pan-Cancer Cohort Study with a Gender Perspective. Cancers, 16(1), 151. https://doi.org/10.3390/cancers16010151